Discovery of potent inhibitors of receptor protein tyrosine phosphatase sigma through the structure-based virtual screening
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Park, Hwangseo | - |
dc.contributor.author | Chien, Pham Ngoc | - |
dc.contributor.author | Ryu, Seong Eon | - |
dc.date.accessioned | 2022-07-16T13:38:13Z | - |
dc.date.available | 2022-07-16T13:38:13Z | - |
dc.date.created | 2021-05-12 | - |
dc.date.issued | 2012-10 | - |
dc.identifier.issn | 0960-894X | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/164597 | - |
dc.description.abstract | Receptor protein tyrosine phosphatase sigma (PTP sigma) has proved to be a promising target for the development of therapeutics for the treatment of neurological diseases. Here, we report the first example for a successful application of the structure-based virtual screening to identify the novel small-molecule inhibitors of PTP sigma. These inhibitors revealed high potencies with the associated IC50 values ranging from 0.1 to 1.3 mu M and were also screened for having desirable physicochemical properties as a drug candidate. Therefore, they deserve consideration for further development by structure-activity relationship studies to develop therapeutics for neurological diseases. Structural features relevant to the stabilization of the newly identified inhibitors in the active site of PTP sigma are discussed in detail. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | PERGAMON-ELSEVIER SCIENCE LTD | - |
dc.title | Discovery of potent inhibitors of receptor protein tyrosine phosphatase sigma through the structure-based virtual screening | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Ryu, Seong Eon | - |
dc.identifier.doi | 10.1016/j.bmcl.2012.08.081 | - |
dc.identifier.scopusid | 2-s2.0-84866738721 | - |
dc.identifier.wosid | 000309609500004 | - |
dc.identifier.bibliographicCitation | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, v.22, no.20, pp.6333 - 6337 | - |
dc.relation.isPartOf | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | - |
dc.citation.title | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | - |
dc.citation.volume | 22 | - |
dc.citation.number | 20 | - |
dc.citation.startPage | 6333 | - |
dc.citation.endPage | 6337 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalResearchArea | Chemistry | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Medicinal | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Organic | - |
dc.subject.keywordPlus | SOLVATION | - |
dc.subject.keywordPlus | PROTEOGLYCAN | - |
dc.subject.keywordPlus | REGENERATION | - |
dc.subject.keywordPlus | HOMOLOGY | - |
dc.subject.keywordPlus | INJURY | - |
dc.subject.keywordAuthor | Virtual screening | - |
dc.subject.keywordAuthor | Docking | - |
dc.subject.keywordAuthor | PTP sigma | - |
dc.subject.keywordAuthor | Inhibitor | - |
dc.subject.keywordAuthor | Drug design | - |
dc.identifier.url | https://www.sciencedirect.com/science/article/pii/S0960894X1201092X?via%3Dihub | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.